Parsabiv

etelcalcetide · Amgen

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Parsabiv, covering 2017-02-07 to 2026-08-18. Get the full timeline:

Most recent: EMA Authorised: Parsabiv (etelcalcetide hydrochloride) — Amgen Europe B.V.